• Rat AMH (Anti-Mullerian Hormone) CLIA Kit (STJC0001811)

Rat AMH (Anti-Mullerian Hormone) CLIA Kit (STJC0001811)

SKU:
STJC0001811

Shipping:
Free Shipping
Current Stock:
Applications: CLIA
Reactivity: Rat
Note: FOR SCIENTIFIC EDUCATIONAL RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR OTHER MEDICAL APPLICATIONS.
Sensitivity: 18.75pg/mL
Detection Limit: 31.25~2000pg/mL
Short Description: This rat AMH kit is a highly sensitive in-vitro chemiluminescent immunoassay for the measurement of trace amounts of analytes.
Storage Instruction: If unopened the kit may be stored at 2-8°C for up to 1 month. If the kit will not be used within 1 month, store the components separately, according to the component table in the manual.
Assay Time: 3.5h
Detection: Chemiluminescence
Gene Symbol: Amh
Gene ID: 25378
Uniprot ID: MIS_RAT
Specificity: This kit recognizes Rat AMH in samples. No significant cross-reactivity or interference between Rat AMH and analogues was observed.
Sample Type: Serum, plasma and other biological fluids
Tissue Specificity Mainly expressed in granulosa cells from preantral and small antral follicles.
Post Translational Modifications Preproprotein is proteolytically processed to generate N- and C-terminal cleavage products that homodimerize and associate to form a biologically active non-covalent complex. Binding of the non-covalent complex to AMHR2 induces dissociation of the pro-region from the mature C-terminal dimer. The N-terminal portion of the protein, despite having no intrinsic activity, has the role of amplifying the activity of the C-terminus.
Function Plays an important role in several reproductive functions. Induces Muellerian duct regression during male fetal sexual differentiation and plays a role in Leydig cell differentiation and function. In female acts as a negative regulator of the primordial to primary follicle transition and decreases FSH sensitivity of growing follicles. AMH signals by binding to a specific type-II receptor, AMHR2, that heterodimerizes with type-I receptors (ACVR1 and BMPR1A), and recruiting SMAD proteins that are translocated to the nucleus to regulate target gene expression.
Protein Name Muellerian-Inhibiting Factor
Anti-Muellerian Hormone
Amh
Muellerian-Inhibiting Substance
Mis
Database Links Reactome: R-RNO-201451
Cellular Localisation Secreted
Alternative CLIA Names Muellerian-Inhibiting Factor CLIA kit
Anti-Muellerian Hormone CLIA kit
Amh CLIA kit
Muellerian-Inhibiting Substance CLIA kit
Mis CLIA kit
Amh CLIA kit
Specificity This kit recognizes Rat AMH in samples. No significant cross-reactivity or interference between Rat AMH and analogues was observed.
Reproducibility Both intra-CV and inter-CV are

Information sourced from Uniprot.org


Item Specifications Storage
Micro CLIA Plate (Dismountable) 96T: 8 wells ×12 strips strips -20℃, 6 months
Reference Standard 96T: 2 vials 48T: 1 vial -20℃, 6 months
Concentrated Biotinylated Detection Ab (100×) 96T: 1 vial, 120 μL 60 μL -20℃, 6 months
Concentrated HRP Conjugate (100×) 96T: 1 vial, 120 μL 60 μL -20℃ (Protect from light), 6 months
Reference Standard & Sample Diluent 1 vial, 20 mL 2-8°C, 6 months
Biotinylated Detection Ab Diluent 1 vial, 14 mL 2-8°C, 6 months
HRP Conjugate Diluent 1 vial, 14 mL 2-8°C, 6 months
Concentrated Wash Buffer (25×) 1 vial, 30 mL 2-8°C, 6 months
Substrate Reagent A 1 vial, 5 mL 2-8℃ (Protect from light)
Substrate Reagent B 1 vial, 5 mL 2-8℃ (Protect from light)
Plate Sealer 5 pieces
Manual 1 copy
Certificate of Analysis 1 copy

Sample Type Range (%) Average Recovery (%)
Serum(n=8) 94-106 101
EDTA plasma(n=8) 99-111 104
Cell culture media(n=8) 100-113 106

Intra-assay Precision Intra-assay Precision Intra-assay Precision Inter-assay Precision Inter-assay Precision Inter-assay Precision
Sample 1.00 2.00 3.00 1.00 2.00 3.00
n 20.00 20.00 20.00 20.00 20.00 20.00
Mean (pg/mL) 99.33 195.40 990.02 106.12 191.42 1043.02
Standard deviation 10.04 14.23 109.79 10.03 20.85 109.00
CV (%) 10.11 7.28 11.09 9.45 10.89 10.45
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance